New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
Researchers at UW’s School of Medicine and the Institute for Research in Biomedicine Barcelona may have found an additional ...
Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...
By Dennis Thompson HealthDay ReporterFRIDAY, Oct. 17, 2025 (HealthDay News) — A new Guinness World Record for fastest whole ...
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...
"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...
Newswatch 16's Justin Gick spoke with an oncologist about the risk factors for breast cancer and treatment options available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback